Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Benitec Biopharma Inc. Common Stock (BNTC)

Pharmaceutical Preparations

https://www.benitec.com

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

3940 TRUST WAY
HAYWARD, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/11/2012

Market Cap

85,933,572

Shares Outstanding

2,570,000

Weighted SO

2,572,434

Total Employees

N/A

Upcoming Earnings

09/19/2024

Similar Tickers

BPTH --.--%

CBIO --.--%

DFFN --.--%

CAPR --.--%

NXTC --.--%

EFTR --.--%

LABP --.--%

APGN --.--%

NAVB --.--%

Beta

0.9140

Last Div

0.0000

Range

2.33-10.88

Chg

-0.0800

Avg Vol

35759

Mkt Cap

85933572

Exch

NASDAQ

Country

US

Phone

510 780 0819

DCF Diff

7.7693

DCF

0.7507

Div Yield

0.0000

P/S

6610.2748

EV Multiple

-3.3806

P/FV

1.9330

Div Yield %

0.0000

P/E

-1.0248

PEG

-0.0162

Payout

0.0000

Current Ratio

4.1798

Quick Ratio

4.1798

Cash Ratio

4.1187

DSO

1488.0769

DIO

0.0063

Op Cycle

1488.0833

DPO

4311.2319

CCC

-2823.1486

Gross Margin

-4.3077

Op Margin

-1653.4615

Pretax Margin

-1668.6154

Net Margin

-1668.6154

Eff Tax Rate

0.0076

ROA

-1.4462

ROE

-1.7536

ROCE

-1.8591

NI/EBT

1.0000

EBT/EBIT

1.0092

EBIT/Rev

-1653.4615

Debt Ratio

0.0236

D/E

0.0308

LT Debt/Cap

0.0054

Total Debt/Cap

0.0299

Int Coverage

-1791.2500

CF/Debt

-57.2732

Equity Multi

1.3043

Rec Turnover

0.2453

Pay Turnover

0.0847

Inv Turnover

57500.0000

FA Turnover

0.0241

Asset Turnover

0.0009

OCF/Share

-7.7706

FCF/Share

-7.8398

Cash/Share

5.4255

OCF/Sales

-1559.5924

FCF/OCF

1.0089

CF Coverage

-57.2732

ST Coverage

-69.4339

CapEx Coverage

-112.3725

Div&CapEx Cov

-112.3725

P/BV

1.9330

P/B

1.9330

P/S

6610.2748

P/E

-1.0248

P/FCF

-4.2011

P/OCF

-1.0964

P/CF

-1.0964

PEG

-0.0162

P/S

6610.2748

EV Multiple

-3.3806

P/FV

1.9330

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.00 06/01/2018 05/25/2018 06/04/2018 06/08/2018